What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Molecular biology, Tissue factor, Biochemistry, Thromboplastin and Gene.
His Molecular biology research is multidisciplinary, incorporating elements of Maf Transcription Factors, Transcription factor, NF-E2 Transcription Factor, RNA and Binding site.
His research in Tissue factor intersects with topics in Receptor, Factor VII, Thrombin and Cell biology.
The study incorporates disciplines such as Chromatography and Bacillus cereus in addition to Biochemistry.
His Thromboplastin study combines topics from a wide range of disciplines, such as Immunology, Pathology, Cycloheximide and Phytohaemagglutinin.
Gene is a primary field of his research addressed under Genetics.
His most cited work include:
- Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor (841 citations)
- CpG islands as gene markers in the human genome. (782 citations)
- Tolerance for mutations and chemical modifications in a siRNA. (641 citations)
What are the main themes of his work throughout his whole career to date?
Hans Prydz focuses on Molecular biology, Biochemistry, Tissue factor, Thromboplastin and Internal medicine.
His research investigates the connection with Molecular biology and areas like Genetics which intersect with concerns in Computational biology.
His Biochemistry study frequently intersects with other fields, such as Chromatography.
Hans Prydz has included themes like Endothelial stem cell, Factor VII, Immunology and Cell biology in his Tissue factor study.
As a part of the same scientific study, Hans Prydz usually deals with the Thromboplastin, concentrating on Phytohaemagglutinin and frequently concerns with Cycloheximide.
His Internal medicine research focuses on Endocrinology and how it relates to In vitro.
He most often published in these fields:
- Molecular biology (33.33%)
- Biochemistry (30.00%)
- Tissue factor (26.67%)
What were the highlights of his more recent work (between 1999-2009)?
- Tissue factor (26.67%)
- Biochemistry (30.00%)
- Molecular biology (33.33%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Tissue factor, Biochemistry, Molecular biology, Cell biology and Factor VII.
His Tissue factor research includes elements of Integral membrane protein, Cancer research, Small interfering RNA, Immunology and Pathology.
His work on Enzyme, Nucleic acid, Beta oxidation and adipocyte protein 2 as part of his general Biochemistry study is frequently connected to Free fatty acid receptor 1, thereby bridging the divide between different branches of science.
His studies deal with areas such as RNA, RNA interference, Messenger RNA and Thrombin as well as Molecular biology.
The various areas that he examines in his Factor VII study include Factor X, Endocrinology and Thromboplastin.
The Trans-acting siRNA study combines topics in areas such as RNA silencing and MRNA cleavage.
Between 1999 and 2009, his most popular works were:
- Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor (841 citations)
- Tolerance for mutations and chemical modifications in a siRNA. (641 citations)
- An algorithm for selection of functional siRNA sequences (360 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Molecular biology, RNA interference, RNA, Tissue factor and Small interfering RNA.
His work deals with themes such as Serine protease, Electrophoretic mobility shift assay, Thromboplastin, NFKB1 and Activator, which intersect with Molecular biology.
His RNA interference study integrates concerns from other disciplines, such as Small hairpin RNA, Gene knockdown, Transfection, Cell biology and Computational biology.
His RNA research is within the category of Biochemistry.
His biological study spans a wide range of topics, including Cell culture, Gene expression, MRNA stabilization, Pathology and p38 mitogen-activated protein kinases.
While the research belongs to areas of Small interfering RNA, Hans Prydz spends his time largely on the problem of In vivo, intersecting his research to questions surrounding DNA, Genomic library, Protein secondary structure and RNA Stability.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
